Importantly, treatment with the ECM‐modulating agent DHB, which reduces collagen deposition (Figure 4D–G; Figure S4B,C, Supporting Information), did not expand the area of these pockets but instead facilitated a more uniform distribution of CD8+ T cells throughout the tumor tissue. The gene discussed is CD8A; the disease is neoplasm.